These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3440109)

  • 1. The lipid risk factor in hypertension and cardiovascular disease.
    Castelli WD
    Br J Clin Pharmacol; 1987; 24 Suppl 1(Suppl 1):59S-60S. PubMed ID: 3440109
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypertension and high blood levels of fats not hazardous?].
    Levin R
    Lakartidningen; 1997 Mar; 94(10):812. PubMed ID: 9102501
    [No Abstract]   [Full Text] [Related]  

  • 3. [Epidemiological study on plasma lipid among patients with cardiovascular disease in 9 cities of the Pearl River Delta region].
    Atherosclerosis Group, Geriatrics Division of Guangdong Province Medical Association
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Sep; 37(9):849-53. PubMed ID: 20128388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dislypidemia as a risk factor for cardiovascular disease].
    Anghel L; Ghiuru R; Gavrilescu CM
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):977-81. PubMed ID: 21500446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid profile parameters in Malaysian dyslipidemic patients.
    Al-Khateeb A; Mohamed MS; Imran K; Ibrahim S; Zilfalil BA; Yusof Z
    Kobe J Med Sci; 2011 Dec; 57(2):E38-48. PubMed ID: 22926072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive therapy and blood lipids: ACE inhibitors.
    Agner E
    Scand J Clin Lab Invest Suppl; 1990; 199():55-9. PubMed ID: 2191418
    [No Abstract]   [Full Text] [Related]  

  • 7. Relation between obesity and the attainment of optimal blood pressure and lipid targets in high vascular risk outpatients.
    Bhan V; Yan RT; Leiter LA; Fitchett DH; Langer A; Lonn E; Tan M; Silagy S; Goodman SG; Yan AT;
    Am J Cardiol; 2010 Nov; 106(9):1270-6. PubMed ID: 21029823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Primary prevention of cardiovascular diseases by lowering lipids].
    Klose G
    Internist (Berl); 1997 Jun; 38(6):615-6. PubMed ID: 9265009
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cardiovascular risk factors in essential hypertension].
    Kékes E; Berentey E
    Orv Hetil; 2001 Apr; 142(16):819-25. PubMed ID: 11340943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonfasting versus fasting lipid profile for cardiovascular risk prediction.
    Langsted A; Nordestgaard BG
    Pathology; 2019 Feb; 51(2):131-141. PubMed ID: 30522787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cardiorespiratory fitness on plasma lipid levels.
    Parto P; Lavie CJ; Swift D; Sui X
    Expert Rev Cardiovasc Ther; 2015 Nov; 13(11):1177-83. PubMed ID: 26436463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Feasibility of correcting lipid metabolism in patients with cardiovascular diseases using a balanced vegetarian diet].
    Medkova IL; Mosiakina LI; Pavlova VE; Bugaev VA; Zharkov AP; Koryshev VI
    Vopr Pitan; 1996; (2):29-32. PubMed ID: 8967054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. USAFAM cardiovascular disease followup study: comparisons of serum lipid and lipoprotein levels.
    Clark DA; Allen MF; Wilson FH
    Aerosp Med; 1974 Oct; 45(10):1167-70. PubMed ID: 4429057
    [No Abstract]   [Full Text] [Related]  

  • 14. Study of basal lipid profile and alimentary lipaemia in cardiovascular disorders.
    Sharma RN; Kotiyal JP; Singh DS; Bisht DB
    J Assoc Physicians India; 1981 Aug; 29(8):597-602. PubMed ID: 7338492
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of low molecular weight procyanidin rich extract from french maritime pine bark on cardiovascular disease risk factors in stage-1 hypertensive subjects: Randomized, double-blind, crossover, placebo-controlled intervention trial.
    Valls RM; Llauradó E; Fernández-Castillejo S; Puiggrós F; Solà R; Arola L; Pedret A
    Phytomedicine; 2016 Nov; 23(12):1451-1461. PubMed ID: 27765365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac malformations and hypertension, but not metabolic risk factors, are common in Turner syndrome.
    Landin-Wilhelmsen K; Bryman I; Wilhelmsen L
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4166-70. PubMed ID: 11549644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive study on the serum lipid profile and risk factor analysis for cardiovascular diseases in a cross-sectional Indian population.
    Kumar MV; Sambaia K; Ramesh BN; Manohar B; Lokesh BR
    J Indian Med Assoc; 2010 Mar; 108(3):156, 158-60. PubMed ID: 21043353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Behavior of the triglycerides and cholesterol in diabetics with vascular changes].
    GRAGNOLI G; BOCCI F
    Riforma Med; 1960 Jul; 74():877-85. PubMed ID: 13707709
    [No Abstract]   [Full Text] [Related]  

  • 19. [Metabolic angiopathic syndrome--interplay between metabolism and vascular wall].
    Nilsson P; Lindholm L; Scherstén B
    Lakartidningen; 1992 Jul; 89(28-29):2437-9. PubMed ID: 1507962
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma lipids and hypertension: response to calcium supplementation.
    Karanja N; Morris CD; Illingworth DR; McCarron DA
    Am J Clin Nutr; 1987 Jan; 45(1):60-5. PubMed ID: 3799505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.